15 nuovi farmaci in commercio

Nuove specialitÓ medicinali: Bravela, Ecuhead, Esbriet, Isodifa, Tookad, Tremfya. 7 nuovi farmaci equivalenti

Nuove specialità medicinali
BRAVELA 24 cpr riv 3 mg + 0,02 mg drospirenone/etinilestradiolo
EXELTIS HEALTHCARE S.L. AIC:042627012 12,20€ Cnn/RR in commercio dal:10/10/2018

ECUHEAD 6 cpr orodispers 10 mg rizatriptan benzoato
TILLOMED AIC:045002045 14,16€ A /RR in commercio dal:12/10/2018

ESBRIET 63 cpr riv 267 mg pirfenidone
ROCHE AIC:041271154 945,09€ H /RNRL in commercio dal:15/10/2018

ESBRIET 252 cpr riv 267 mg pirfenidone
ROCHE AIC:041271166 3780,34€ H /RNRL in commercio dal:15/10/2018

ESBRIET 84 cpr riv 801 mg pirfenidone
ROCHE AIC:041271178 3780,34€ H /RNRL in commercio dal:15/10/2018

ISODIFA 30 cps molli 30 mg isotretinoina
DIFA COOPER AIC:045513177 32,49€ A /RNR in commercio dal:09/10/2018

TOOKAD EV 1 flaconcino 183 mg padeliporfina potassico
STEBA BIOTECH S.A. AIC:045774015 €10.361,00 Cnn/OSP in commercio dal:19/10/2018

TREMFYA SC 1 siringa 100 mg/1 ml guselkumab
JANSSEN CILAG AIC:045772011 3404,74€ H /RRL in commercio dal:12/10/2018

Nuovi farmaci equivalenti
CIQORIN 50 cps molli 10 mg ciclosporina
TEVA ITALIA Srl AIC:042787251 10,17€ A /RNR in commercio dal:12/10/2018

EFAVIRENZ EMTRICITABINA TENOFOVIR DISOPROXIL EG 30 cpr 600 mg+ 245 mg + 200 mg efavirenz/emtricitabina/tenofovir disoproxil succinato
EG SpA AIC:045507011 396,04€ H /RNRL in commercio dal:10/10/2018

ELETRIPTAN EG 6 cpr riv 40 mg eletriptan bromidrato
EG SpA AIC:045017124 18,57€ A /RR in commercio dal:11/10/2018

RANITIDINA AUROBINDO 20 cpr riv 150 mg ranitidina cloridrato
AUROBINDO PHARMA ITALIA Srl AIC:045309022 3,29€ A /RR in commercio dal:12/10/2018

TELMISARTAN IDROCLOROTIAZIDE ACCORD 28 cpr 40 mg + 12,5 mg telmisartan/idroclorotiazide
ACCORD HEALTHCARE ITALIA Srl AIC:043929025 6,50€ A /RR in commercio dal:09/10/2018

TELMISARTAN IDROCLOROTIAZIDE ACCORD 28 cpr 80 mg + 25 mg telmisartan/idroclorotiazide
ACCORD HEALTHCARE ITALIA Srl AIC:043929203 7,35€ A /RR in commercio dal:09/10/2018

TELMISARTAN IDROCLOROTIAZIDE ACCORD 28 cpr 80 mg + 12,5 mg telmisartan/idroclorotiazide
ACCORD HEALTHCARE ITALIA Srl AIC:043929114 7,35€ A /RR in commercio dal:09/10/2018